Preclinical Human and Murine Models of Hepatocellular Carcinoma (HCC) - 13/07/24
Cet article a été publié dans un numéro de la revue, cliquez ici pour y accéder
Abstract |
Hepatocellular carcinoma (HCC) is the most frequent liver cancer, which account for more than 90 % of all liver cancer cases. It is the fifth leading cause of cancer globally and the second leading cause of cancer-related mortality in men. The availability of competent HCC preclinical models is fundamental to the success of mechanistic studies, molecular target identification, and drug testing. However, there are challenges associated with the use of these models. In this review, we provided updates on various cell lines, animals, and human HCC models, their specific preclinic use and associated potential challenges. Overall, the understanding of the merits and demerits of a particular HCC model will improve model selection for various preclinical studies.
Le texte complet de cet article est disponible en PDF.Key words : HCC, Preclinical Murine Model, Preclinical Human Model, Liver Cancer
Plan
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?